The management of pediatric solid tumors in the department follows the advanced concept of multidisciplinary cooperation. In our hospital, the multidisciplinary cooperative group is consisted of pediatric oncologists, pediatric surgeons, radiologist, and pathologists, which is fully referring to the American Children’s Oncology Group (COG) or The European Collaborative Group on Childhood Oncology (SIOP) criteria for the diagnosis and treatment of pediatric solid tumor. The purpose is to accurately diagnose, accurately stage and group each child with solid tumor, and to provide the accurately individualized treatment. Our team strives to provide the most intimate one-stop treatment guidance for every child with tumors. Classic malignant diseases in our department include: various types of lymphomas and brain tumors, neuroblastoma, Wilms tumor, hepatoblastoma, various sarcomas and fibroids, etc.

In addition to children’s malignant solid tumors, the treatment of children’s hemangioma and lymphangioma is also one of the unique features of our department. Hemangiomas and vascular malformations are benign tumors with high incidence in childhood and can cause serious harm. The usual treatment methods are limited. Our department mainly adopts medication treatment methods, combines with ultrasound-guided interventional therapy as a supplement, forms a unique system in the treatment of hemangioma and lymphangioma and avoids the side effects of surgical recurrence, radioactive application and laser treatment. The featured technology in our department includes Bleomycin intra-tumor injection for the treatments of infantile hemangioma and vascular malformations. In the department of pediatric oncology and pediatric ultrasound room, there are fixed doctors to perform the multidisciplinary consultation to decide the optimal treatment plan for the child.